Edition:
United States

Acasti Pharma Inc (ACST.O)

ACST.O on Consolidated Issue listed on NASDAQ Capital Market

1.23USD
22 May 2017
Change (% chg)

-- (--)
Prev Close
$1.23
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
107,534
52-wk High
$3.09
52-wk Low
$1.11

Select another date:

Wed, Apr 12 2017

BRIEF-Acasti Pharma says has successfully completed two Phase 1, two Phase 2 clinical trials with Capre

* Acasti Pharma Inc - has successfully completed two Phase 1 and two Phase 2 clinical trials with Capre for treatment of hypertriglyceridemia

BRIEF-Acasti Pharma provides update on Capre phase 3 development program

* Acasti Pharma provides update on Capre phase 3 development program

BRIEF-Acasti Pharma announces pricing for its public offering of units

* Acasti Pharma announces pricing for its public offering of units

BRIEF-Acasti Pharma Q3 loss C$0.22/shr

* Acasti pharma - Had cash,short-term investments of $5.8 million as of Nov 30, 2016

BRIEF-Acasti Pharma appoints Linda O'keefe as chief financial officer

* Acasti Pharma appoints Linda O'keefe as chief financial officer

Select another date:

More From Around the Web